Table I.
Pathways enriched with DEGs in lung samples from mice with MODS compared with healthy controls.
A, Pathways that upregulated DEGs in lung samples from MODS mice were enriched in | |||
---|---|---|---|
Pathway | P-value | Gene count | DEGs |
mmu04060: Cytokine-cytokine receptor interaction | 7.75×10−22 | 52 | Il17Ra, Cxcl10, Il18Rap, Cd40, Osm, Inhba, Tnfrsf9, Ccr7, Cxcl1, IL-6… |
mmu04062: Chemokine signaling pathway | 2.32×10−16 | 39 | Cxcl1, Cxcl10, Stat1, Ccr5, Cxcl13, Cxcl16, Ccr2, Jak2, Jak3, Xcl1… |
mmu04620: Toll-like receptor signaling pathway | 4.06×10−12 | 25 | Ccl3, Tnf, Cxcl10, Myd88, IL-6, Cd40, Stat1, Ripk1, Irf7, Cd14… |
mmu04621: NOD-like receptor signaling pathway | 8.60×10−11 | 19 | Cxcl1, IL-6, Tnf, Ccl2, Cxcl2, Ccl8, Nfkbia, Nlrp3, Ccl5, Ccl7… |
mmu04630: Jak-STAT signaling pathway | 7.80×10−7 | 23 | Csf3, Socs1, Pim1, Stat1, Il7R, Stat2, Csf2Rb, Jak2, Pik3R5, Jak3… |
B, Pathways that downregulated DEGs in lung samples from MODS mice were enriched in | |||
Pathway | P-value | Gene count | DEGs |
mmu00982: Drug metabolism | 5.02×10−8 | 12 | Gstm1, Gsta2, Gsta3, Cyp2D22, Adh1, Fmo1, Fmo2, Fmo3, Maob, Aldh3A1… |
mmu00980: Metabolism of xenobiotics by cytochrome P450 | 1.68×10−6 | 10 | Gstm1, Gsta2, Gsta3, Cyp2F2, Cyp1A1, Adh1, Gstt1, Ephx1, Cyp2E1, Aldh3A1 |
mmu04512: ECM-receptor interaction | 5.56×10−4 | 8 | Lama2, Col4A4, Tnxb, Npnt, Itga8, Vtn, Thbs3, Chad |
mmu05414: Dilated cardiomyopathy | 1.03×10−3 | 8 | Lama2, Actc1, Adrb1, Adcy8, Pln, Itga8, Myh7, Tnni3 |
mmu00340: Histidine metabolism | 8.94×10−3 | 4 | Hnmt, Acy3, Maob, Aldh3A1 |
DEGs, differentially expressed genes; MODS, multiple organ dysfunction syndrome. DEGs were listed in the table based on P-value and |log2 FC| value of these DEGs.